1. Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer, and also serves as a director of the issuer. 2. This transaction was originally reported as 130,000 when the correct number was actually 140,000. 3. Of the 30,366,536 shares of common stock, 22,767,183 shares of common stock are owned indirectly through EI and 7,599,356 shares are owned directly by the reporting person.